UroMems
FranceWho owns UroMems?
UroMems is a French MedTech company, currently owned by Cita Investissement since 2024 and 4 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Wellington Partners, Supernova Invest, Cita Investissement, Crédit Mutuel Equity and Crédit Mutuel Innovation since 2016.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Amorcage Technologique Investissement
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns UroMems?
UroMems is currently owned by Cita Investissement, Crédit Mutuel Equity and 3 others, through Amorcage Technologique Investissement, since 2024.
When did Cita Investissement and 4 others acquire UroMems?
Cita Investissement and 4 others acquired UroMems in 2024.
Who has owned UroMems over time?
UroMems has been through 5 private-equity ownership periods: Wellington Partners · via Wellington Partners Life Sciences · since 2016; Supernova Invest · via Amorcage Technologique Investissement · since 2016; Cita Investissement · via CITA Investissement · since 2024; Crédit Mutuel Equity · via Crédit Mutuel Equity · since 2024; Crédit Mutuel Innovation · via Crédit Mutuel Innovation Evergreen Capital · since 2024.